BIO-RAD LABORATORIES, INC. Quarterly Operating Lease, Payments in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Bio Rad Laboratories, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2018 to Q2 2024.
  • Bio Rad Laboratories, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $10.5M, a 7.14% increase year-over-year.
  • Bio Rad Laboratories, Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $42.7M, a 8.93% increase year-over-year.
  • Bio Rad Laboratories, Inc. annual Operating Lease, Payments for 2023 was $41M, a 7.61% increase from 2022.
  • Bio Rad Laboratories, Inc. annual Operating Lease, Payments for 2022 was $38.1M, a 6.39% decline from 2021.
  • Bio Rad Laboratories, Inc. annual Operating Lease, Payments for 2021 was $40.7M, a 8.33% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $42.7M $10.5M +$700K +7.14% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $42M $10.9M +$1M +10.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $41M $10.7M +$700K +7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 $40.3M $10.6M +$1.1M +11.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-27
Q2 2023 $39.2M $9.8M +$700K +7.69% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $38.5M $9.9M +$400K +4.21% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $38.1M $10M +$200K +2.04% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 $37.9M $9.5M +$2.3M +31.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $35.6M $9.1M -$2.8M -23.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $38.4M $9.5M -$2.3M -19.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $40.7M $9.8M -$1.5M -13.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $42.2M $7.2M -$3.6M -33.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $45.8M $11.9M +$1M +9.17% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 $44.8M $11.8M +$400K +3.51% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $44.4M $11.3M -$1.3M -10.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $45.7M $10.8M -$800K -6.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $46.5M $10.9M -$400K -3.54% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $46.9M $11.4M -$300K -2.56% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $47.2M $12.6M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-11
Q3 2019 $11.6M Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $11.3M Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $11.7M +$11.7M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.